A prediction model of working memory across health and psychiatric disease using whole-brain functional connectivity
Abstract
Working memory deficits are present in many neuropsychiatric diseases with diagnosis-related severity. However, it is unknown whether this common behavioral abnormality is a continuum explained by a neural mechanism shared across diseases or a set of discrete dysfunctions. Here, we performed predictive modeling to examine working memory ability (WMA) as a function of normative whole-brain connectivity across psychiatric diseases. We built a quantitative model for letter 3-back task performance in healthy participants, using resting state functional magnetic resonance imaging (rs-fMRI). This normative model was applied to independent participants (N = 965) including four psychiatric diagnoses. Individual's predicted WMA significantly correlated with a measured WMA in both healthy population and schizophrenia. Our predicted effect size estimates on WMA impairment were comparable to previous meta-analysis results. These results suggest a general association between brain connectivity and working memory ability applicable commonly to health and psychiatric diseases.
Data availability
The following dataset was generated: Yamashita, M, Yoshihara, Y, Hashimoto, R, Yahata, N, Ichikawa, N, Sakai, Y, ... Imamizu, H, 2018, Working Memory Prediction Database, https://bicr.atr.jp/dcn/en/download/database-wmp/. A download link for the open access dataset will be sent after the application form for data usage is completed (https://bicr.atr.jp/dcn/wp-content/uploads/Application_Form_for_Data_Usage_WMP-3.pdf). MATLAB code used to build the prediction model are also shared via this download link. You can send the completed application form to dcn_db@atr.jp. The Human Connectome Project 500 Subjects Release Open Access dataset is available from ConnectomeDB (https://db.humanconnectome.org/app/template/Login.vm) after the creation of a free account. Before accessing the dataset, users must agree with the Open Access Data Use Terms from ConnectomeDB (further information can be found here https://www.humanconnectome.org/study/hcp-young-adult/document/500-subjects-data-release and here https://www.humanconnectome.org/study/hcp-young-adult/data-use-terms).
Article and author information
Author details
Funding
Ministry of Education, Culture, Sports, Science, and Technology (JP18dm0307008)
- Mitsuo Kawato
Wellcome
- Ben Seymour
ImPACT Program of Council for Science, Technology and Innovation
- Masahiro Yamashita
- Mitsuo Kawato
- Hiroshi Imamizu
JSPS KAKENHI (26120002)
- Hiroshi Imamizu
Arthritis Research UK (21357)
- Ben Seymour
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Reviewing Editor
- Michael Breakspear, QIMR Berghofer Medical Research Institute, Australia
Ethics
Human subjects: ATR dataset was acquired using protocol (#12-101) according to the Declaration of Helsinki and approved by the Ethics Committee at Advanced Telecommunication Research Institute International. All participants gave written informed consent.Data from SCZ group was acquired by study design that was approved by the Committee on Medical Ethics (#R0027) of Kyoto University and was conducted in accordance with the Code of Ethics of the World Medical Association. All participants gave written informed consent.Data from MDD group was acquired by study protocol (#E-38) that was approved by the Ethics Committee of Hiroshima University. All participants gave written informed consent.Data from OCD group was acquired by study protocol (#RBMR-C-1098-5) that was approved by the Medical Committee on Human Studies at the Kyoto Prefectural University of Medicine. All participants gave written informed consent.Data from ASD group at the University of Tokyo was acquired by study protocol (#3048 and #3150) approved by the Ethics Committee of the Graduate School of Medicine and Faculty of Medicine at the University of Tokyo. All participants gave written informed consent.Data from ASD group at Showa University was aqcuired by study protocol (#893) that was approved by Ethics Committee of the Faculty of Medicine of Showa University. All participants gave written informed consent.
Version history
- Received: June 1, 2018
- Accepted: December 8, 2018
- Accepted Manuscript published: December 10, 2018 (version 1)
- Version of Record published: January 8, 2019 (version 2)
Copyright
© 2018, Yamashita et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 5,037
- Page views
-
- 682
- Downloads
-
- 55
- Citations
Article citation count generated by polling the highest count across the following sources: Scopus, Crossref, PubMed Central.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Neuroscience
Memory formation depends on neural activity across a network of regions, including the hippocampus and broader medial temporal lobe (MTL). Interactions between these regions have been studied indirectly using functional MRI, but the bases for interregional communication at a cellular level remain poorly understood. Here, we evaluate the hypothesis that oscillatory currents in the hippocampus synchronize the firing of neurons both within and outside the hippocampus. We recorded extracellular spikes from 1854 single- and multi-units simultaneously with hippocampal local field potentials (LFPs) in 28 neurosurgical patients who completed virtual navigation experiments. A majority of hippocampal neurons phase-locked to oscillations in the slow (2–4 Hz) or fast (6–10 Hz) theta bands, with a significant subset exhibiting nested slow theta × beta frequency (13–20 Hz) phase-locking. Outside of the hippocampus, phase-locking to hippocampal oscillations occurred only at theta frequencies and primarily among neurons in the entorhinal cortex and amygdala. Moreover, extrahippocampal neurons phase-locked to hippocampal theta even when theta did not appear locally. These results indicate that spike-time synchronization with hippocampal theta is a defining feature of neuronal activity in the hippocampus and structurally connected MTL regions. Theta phase-locking could mediate flexible communication with the hippocampus to influence the content and quality of memories.
-
- Developmental Biology
- Neuroscience
Down syndrome (DS) is characterized by skeletal and brain structural malformations, cognitive impairment, altered hippocampal metabolite concentration and gene expression imbalance. These alterations were usually investigated separately, and the potential rescuing effects of green tea extracts enriched in epigallocatechin-3-gallate (GTE-EGCG) provided disparate results due to different experimental conditions. We overcame these limitations by conducting the first longitudinal controlled experiment evaluating genotype and GTE-EGCG prenatal chronic treatment effects before and after treatment discontinuation. Our findings revealed that the Ts65Dn mouse model reflected the pleiotropic nature of DS, exhibiting brachycephalic skull, ventriculomegaly, neurodevelopmental delay, hyperactivity, and impaired memory robustness with altered hippocampal metabolite concentration and gene expression. GTE-EGCG treatment modulated most systems simultaneously but did not rescue DS phenotypes. On the contrary, the treatment exacerbated trisomic phenotypes including body weight, tibia microarchitecture, neurodevelopment, adult cognition, and metabolite concentration, not supporting the therapeutic use of GTE-EGCG as a prenatal chronic treatment. Our results highlight the importance of longitudinal experiments assessing the co-modulation of multiple systems throughout development when characterizing preclinical models in complex disorders and evaluating the pleiotropic effects and general safety of pharmacological treatments.